11 – 20 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence
- Contribution to journal › Debate/Note/Editorial
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
- Contribution to journal › Article
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
- Contribution to journal › Article
-
Mark
The influence of domain permutations of an albumin-binding domain-fused her2-targeting affibody-based drug conjugate on tumor cell proliferation and therapy efficacy
- Contribution to journal › Article
-
Mark
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
- Contribution to journal › Article
-
Mark
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer
- Contribution to journal › Article
- 2020
-
Mark
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
- Contribution to journal › Article
- 2018
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
- Contribution to journal › Article
- 2017
-
Mark
Pancreatic cancer stroma : controversies and current insights
- Contribution to journal › Scientific review
